{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:26:31Z","timestamp":1781738791340,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jad.2020.07.063","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T11:11:35Z","timestamp":1595329895000},"page":"883-889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Trends in prescriptions of lithium and other medications for patients with bipolar disorder in office-based practices in the United States: 1996\u20132015"],"prefix":"10.1016","volume":"276","author":[{"given":"Yian","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Mojtabai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando S","family":"Goes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jad.2020.07.063_bib0001","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/bdi.12638","article-title":"Racial disparities in bipolar disorder treatment and research: a call to action","volume":"20","author":"Akinhanmi","year":"2018","journal-title":"Bipolar Disord."},{"issue":"3","key":"10.1016\/j.jad.2020.07.063_bib0002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/wps.20462","article-title":"Who are excellent lithium responders and why do they matter","volume":"16","author":"Alda","year":"2017","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2020.07.063_bib0003","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0028-1103291","article-title":"Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants","volume":"42","author":"Baldessarini","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.jad.2020.07.063_bib0004","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1176\/appi.ajp.159.6.1005","article-title":"Trends in the treatment of bipolar disorder by outpatient psychiatrists","volume":"159","author":"Blanco","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.jad.2020.07.063_bib0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2009.01.024","article-title":"Use of lithium in the adult populations of Denmark, Norway and Sweden","volume":"118","author":"Bramness","year":"2009","journal-title":"J. Affect. Disord"},{"issue":"2","key":"10.1016\/j.jad.2020.07.063_bib0006","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4088\/JCP.09m05214yel","article-title":"Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the systematic treatment enhancement program for bipolar disorder","volume":"72","author":"Brooks","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2020.07.063_bib0007","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement","volume":"2","author":"Cade","year":"1949","journal-title":"Med. J. Aust."},{"issue":"3","key":"10.1016\/j.jad.2020.07.063_bib0008","doi-asserted-by":"crossref","first-page":"138","DOI":"10.9740\/mhc.2018.05.138","article-title":"Antiepileptic drugs and suicide-related outcomes in bipolar disorder: a descriptive review of published data","volume":"8","author":"Caley","year":"2018","journal-title":"Ment. Health Clin."},{"issue":"2\u20133","key":"10.1016\/j.jad.2020.07.063_bib0009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jad.2006.01.005","article-title":"Trends in lithium prescription in Spain from 1985 to 2003","volume":"91","author":"Castells","year":"2006","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.07.063_bib0010","unstructured":"CDC. (2015a). NAMCS scope and sample design. fromhttps:\/\/www.cdc.gov\/nchs\/ahcd\/ahcd_scope.htm."},{"key":"10.1016\/j.jad.2020.07.063_bib0011","unstructured":"CDC. (2015b). Trend analysis using NAMCS and NHAMCS drug data. fromhttps:\/\/www.cdc.gov\/nchs\/ahcd\/trend_analysis.htm."},{"key":"10.1016\/j.jad.2020.07.063_bib0012","unstructured":"CDC. (2017). National Ambulatory Medical Care Survey. fromhttps:\/\/www.cdc.gov\/nchs\/ahcd\/about_ahcd.htm."},{"issue":"2","key":"10.1016\/j.jad.2020.07.063_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/wps.20128","article-title":"Risks of all-cause and suicide mortality in mental disorders: a meta-review","volume":"13","author":"Chesney","year":"2014","journal-title":"World Psychiatry"},{"issue":"Suppl 5","key":"10.1016\/j.jad.2020.07.063_bib0014","first-page":"38","article-title":"Drug interactions of lithium and other antimanic\/mood-stabilizing medications","volume":"64","author":"Dunner","year":"2003","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2020.07.063_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2020.07.063_bib0016","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/cns.12017","article-title":"Combination therapy for manic phases: a critical review of a common practice","volume":"18","author":"Geoffroy","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.jad.2020.07.063_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40345-018-0133-9","article-title":"Antidepressants in bipolar depression: an enduring controversy","volume":"6","author":"Gitlin","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"issue":"6","key":"10.1016\/j.jad.2020.07.063_bib0018","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.jad.2020.07.063_bib0019","doi-asserted-by":"crossref","first-page":"e28725","DOI":"10.1371\/journal.pone.0028725","article-title":"Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009","volume":"6","author":"Hayes","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jad.2020.07.063_bib0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jad.2013.10.054","article-title":"Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011","volume":"155","author":"Hooshmand","year":"2014","journal-title":"J. Affect. Disord."},{"issue":"10023","key":"10.1016\/j.jad.2020.07.063_bib0021","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","article-title":"Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study","volume":"387","author":"Hou","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2020.07.063_bib0022","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/cap.2005.15.26","article-title":"Trends in use of antidepressants, lithium, and anticonvulsants in Kaiser Permanente-insured youths, 1994-2003","volume":"15","author":"Hunkeler","year":"2005","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jad.2020.07.063_bib0023","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/archpsyc.62.8.860","article-title":"Suicide risk in patients treated with lithium","volume":"62","author":"Kessing","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2020.07.063_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00023210-200620010-00003","article-title":"Polytherapy in bipolar disorder","volume":"20","author":"Lin","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2020.07.063_bib0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jad.2017.02.012","article-title":"Maintenance therapy with second generation antipsychotics for bipolar disorder - A systematic review and meta-analysis","volume":"213","author":"Lindstrom","year":"2017","journal-title":"J. Affect. Disord."},{"issue":"9817","key":"10.1016\/j.jad.2020.07.063_bib0026","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jad.2020.07.063_bib0027","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2020.07.063_bib0028","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2020.07.063_bib0029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archgenpsychiatry.2009.175","article-title":"National trends in psychotropic medication polypharmacy in office-based psychiatry","volume":"67","author":"Mojtabai","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2020.07.063_bib0030","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archpsyc.64.9.1032","article-title":"National trends in the outpatient diagnosis and treatment of bipolar disorder in youth","volume":"64","author":"Moreno","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2020.07.063_bib0031","first-page":"211","article-title":"Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder","volume":"10","author":"Nassir Ghaemi","year":"2008","journal-title":"Medscape J. Med."},{"issue":"1","key":"10.1016\/j.jad.2020.07.063_bib0032","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1176\/appi.ajp.2012.12060751","article-title":"Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium","volume":"170","author":"Nierenberg","year":"2013","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2020.07.063_bib0033","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9343(94)90308-5","article-title":"Clinical manifestations and management of acute lithium intoxication","volume":"97","author":"Okusa","year":"1994","journal-title":"Am. J. Med"},{"issue":"6","key":"10.1016\/j.jad.2020.07.063_bib0034","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jpsychires.2009.09.011","article-title":"Borderline personality disorder and the misdiagnosis of bipolar disorder","volume":"44","author":"Ruggero","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"17","key":"10.1016\/j.jad.2020.07.063_bib0035","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","article-title":"Effectiveness of adjunctive antidepressant treatment for bipolar depression","volume":"356","author":"Sachs","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jad.2020.07.063_bib0036","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1755-5949.2011.00258.x","article-title":"State of the art: treatment of bipolar disorders","volume":"18","author":"Severus","year":"2012","journal-title":"CNS Neurosci. Ther."},{"issue":"10","key":"10.1016\/j.jad.2020.07.063_bib0037","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1017\/S1092852900014917","article-title":"The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials","volume":"11","author":"Weisler","year":"2006","journal-title":"CNS Spectr."},{"issue":"1","key":"10.1016\/j.jad.2020.07.063_bib0038","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jad.2008.01.019","article-title":"Changes in outpatient lithium treatment in the Netherlands during 1996-2005","volume":"111","author":"Wilting","year":"2008","journal-title":"J Affect. Disord."},{"issue":"2","key":"10.1016\/j.jad.2020.07.063_bib0039","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720325088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:50:15Z","timestamp":1759024215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720325088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":39,"alternative-id":["S0165032720325088"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.063","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.01.18.20018028","asserted-by":"object"}]},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in prescriptions of lithium and other medications for patients with bipolar disorder in office-based practices in the United States: 1996\u20132015","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.07.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}